Suppr超能文献

大肠杆菌和欧文氏菌天冬酰胺酶对儿童急性淋巴细胞白血病凝血系统的影响极小:一项随机研究。

Minimal effects of E. coli and Erwinia asparaginase on the coagulation system in childhood acute lymphoblastic leukemia: a randomized study.

作者信息

Risseeuw-Appel I M, Dekker I, Hop W C, Hählen K

机构信息

Department of Pediatrics, Sophia Childrens Hospital/University Hospital, Rotterdam, The Netherlands.

出版信息

Med Pediatr Oncol. 1994;23(4):335-43. doi: 10.1002/mpo.2950230404.

Abstract

A randomized study was done in twenty newly diagnosed children with acute lymphoblastic leukemia. Ten children were treated with Escherichia coli L-asparaginase, and ten with Erwinia chrysanthemi L-asparaginase. L-asparaginase (ASP) treatment started halfway during ALL-induction treatment with vincristine, prednisone, daunorubicin and intrathecal methotrexate. The mean activated partial thromboplastin time (APTT) level in all children demonstrated a significant fall (P < 0.001) from 28.25 sec at diagnosis to 23.0 sec at the start of ASP treatment. In this same time interval, the mean fibrinogen level declined markedly from 3 g/l to 1.2 g/l (P < 0.001), probably due to prednisone therapy. The APTT stayed shortened during ASP therapy, whereas the hypofibrinogenemia recovered significantly faster in the Erwinia group (P < or = 0.01). Factors (F) II, V, VII and X stayed within the normal range, while F VIII and F IX were elevated. During the entire period of induction therapy, the ATIII activity remained within the normal range in both treatment groups. The protein C values, however, demonstrated a steady decline from 140% at start of ASP treatment to a mean of 81% and 93%, respectively, at the end of the ASP therapy in the E. coli and Erwinia group. Five of the ten children treated with E. coli ASP demonstrated protein C levels below 70% at the end of ASP therapy, opposed to none of the Erwinia treated patients (P = 0.03). We suggest that the effect of ASP resulting in decreased coagulation factor synthesis is in part counterbalanced by the effect of prednisone on the coagulation system, when ASP is administered at the end of ALL induction treatment. The overall effect of ASP either of E. coli or of Erwinia on the hemorrhagic system reveals a slight imbalance towards thrombosis, mainly because of a gradual decrease in protein C activity. This imbalance is less pronounced in the Erwinia group.

摘要

对20名新诊断的急性淋巴细胞白血病患儿进行了一项随机研究。10名患儿接受大肠杆菌L-天冬酰胺酶治疗,10名患儿接受菊欧文氏菌L-天冬酰胺酶治疗。L-天冬酰胺酶(ASP)治疗在使用长春新碱、泼尼松、柔红霉素和鞘内注射甲氨蝶呤进行ALL诱导治疗的中途开始。所有患儿的平均活化部分凝血活酶时间(APTT)水平从诊断时的28.25秒显著下降(P<0.001)至ASP治疗开始时的23.0秒。在同一时间间隔内,平均纤维蛋白原水平从3g/l显著下降至1.2g/l(P<0.001),这可能是由于泼尼松治疗所致。在ASP治疗期间,APTT持续缩短,而低纤维蛋白原血症在欧文氏菌组恢复得明显更快(P≤0.01)。因子(F)II、V、VII和X保持在正常范围内,而F VIII和F IX升高。在整个诱导治疗期间,两个治疗组的抗凝血酶III活性均保持在正常范围内。然而,蛋白C值从ASP治疗开始时的140%稳步下降,在大肠杆菌组和欧文氏菌组的ASP治疗结束时分别降至平均81%和93%。接受大肠杆菌ASP治疗的10名患儿中有5名在ASP治疗结束时蛋白C水平低于70%,而接受欧文氏菌治疗的患儿中无一例如此(P=0.03)。我们认为,当在ALL诱导治疗结束时给予ASP时,ASP导致凝血因子合成减少的作用部分被泼尼松对凝血系统的作用所抵消。大肠杆菌或欧文氏菌的ASP对出血系统的总体作用显示出向血栓形成的轻微失衡,主要是由于蛋白C活性逐渐降低。这种失衡在欧文氏菌组中不太明显。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验